SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 20, 2003
GTC BIOTHERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Charter)
Massachusetts |
| 0-21794 |
| 04-3186494 |
(State or Other Jurisdiction of |
| (Commission File Number) |
| (IRS Employer Identification |
175 CROSSING BOULEVARD
FRAMINGHAM, MASSACHUSETTS 01702
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (508) 620-9700
Not Applicable
(Former name or former address, if changed since last report)
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
99.1 |
| Press release of GTC Biotherapeutics, Inc. dated February 20, 2003, reporting GTC’s financial results for the fourth quarter of 2002 and for the year 2002. |
|
Item 9. Regulation FD Disclosure.
Attached and incorporated herein by reference as Exhibit 99.1 is a copy of a press release of GTC dated February 20, 2003, reporting GTC’s financial results for the fourth quarter of 2002 and for the year 2002.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 20, 2003 | GTC BIOTHERAPEUTICS, INC. | ||
|
|
|
|
|
|
|
|
| By: |
| /s/ John B. Green |
|
|
| John B. Green |
|
|
| Senior Vice President and Chief Financial Officer |
3
EXHIBIT INDEX
Exhibit |
|
|
|
No. |
| Description |
|
99.1 |
| Press release of GTC Biotherapeutics, Inc. dated February 20, 2003, reporting GTC’s financial results for the fourth quarter of 2002 and for the year 2002. |
|
4
